Semax vs Selank: Which Is Better for Focus & Anxiety?
Semax and Selank are the two most-researched nootropic peptides used via nasal delivery. Both were developed in Russia, both have human safety data, and both target cognition — but through very different mechanisms. Choosing between them (or combining them) depends entirely on what you're trying to address.
Semax & Selank Nasal Sprays
Research-grade nasal spray format from a specialist supplier.
Research context. Semax and Selank are research compounds. While both have human safety data from Russian clinical research, they are not FDA-approved. This article is for educational purposes only.
| Feature | Semax | Selank |
|---|---|---|
| Base compound | ACTH(4-7) analogue (heptapeptide) | Tuftsin analogue (heptapeptide) |
| Primary receptor targets | Melanocortin receptors, BDNF upregulation | GABA-A modulation, tuftsin receptors |
| Dominant effect | Drive, focus, mental energy | Calm, anxiolytic, anxiety reduction |
| Half-life (nasal) | ~20–30 minutes active; effects 4–6 hrs | ~20–30 minutes active; effects 4–8 hrs |
| BDNF effect | Direct upregulation — significant | Minor; primarily GABA/immune modulation |
| Anxiolytic action | Mild secondary effect only | Primary mechanism |
| Best timing | Morning, before demanding cognitive tasks | Morning or pre-stressor situations |
| Stimulant feel | Moderate — some feel mild stimulation | None — calm and even |
| Delivery format | Nasal spray (standard research format) | Nasal spray (standard research format) |
Semax is a synthetic analogue of ACTH(4-7) — a fragment of adrenocorticotropic hormone that lacks cortisol-stimulating activity but retains neuroprotective and cognitive effects. Its most significant action is robust BDNF (brain-derived neurotrophic factor) upregulation. BDNF is critical for synaptic plasticity, memory consolidation, and neuronal survival. Semax also modulates dopaminergic and serotonergic signalling, which produces its characteristic drive and focus effect. Most users describe it as mentally energising without the jitteriness of stimulants.
Selank is derived from tuftsin, an endogenous immunomodulatory peptide, with an added proline extension that increases stability and CNS activity. Its primary action is positive modulation of GABA-A receptors — the same receptor system targeted by benzodiazepines, but with a much gentler profile and no dependency risk identified in research. Selank also has documented immune-modulatory and mild nootropic effects, but its anxiolytic action is its defining quality. Users typically describe calm mental clarity, reduced background noise of anxiety, and improved verbal fluency under stress.
Anxiety suppression allows natural energy to emerge without adding more stimulation on top of an anxious baseline.
BDNF upregulation and dopaminergic effects provide the cognitive edge without needing anxiolysis.
Semax provides the drive; Selank removes performance anxiety. The combination is widely regarded as the most practical nootropic stack in this class.
Lower side-effect burden, smoother introduction to peptide nootropics, better tolerance baseline to establish before adding Semax.
The Semax + Selank combination is arguably the most commonly reported nootropic peptide stack in the research community. The rationale is straightforward: Semax provides cognitive activation and BDNF-driven neuroplasticity; Selank prevents the edge from becoming anxiety and smooths the experience.
Typical combined protocol (research context)
Semax: 100mcg per nostril (200mcg total), morning
Selank: 100mcg per nostril (200mcg total), same time or 30 min after
Cycle: 4–8 weeks on, 2–4 weeks off. Start individually before combining to establish baseline response.
Important: start each compound separately before combining. This allows you to identify what each contributes and catch any individual sensitivity before adding complexity.
Cognitive Peptides Guides
Other Articles
Calculator
Calculate exact reconstitution volumes and insulin unit doses for any peptide protocol.
Open Calculator →